Type 2 Diabetes
To assess whether treatment with permafibrate will prevent myocardial infarction, ischemic stroke, unstable angina, and cardiovascular death in adults with Type 2 Diabetes Mellitus.
Principal Investigator: Marcus McKenzie, MD
Locations: Legacy Heart Center Plano
Sponsor: Kowa Research Institute
IRB Number: 017-488
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will change your care
Alexandria Biberstein, RN469.814.4732Alexandria.Biberstein@BSWHealth.org
Permafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Scott & White Health's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Scott & White Health.